A detailed history of First Personal Financial Services transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Personal Financial Services holds 1 shares of VRTX stock, worth $408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$408
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$460.0 - $505.78 $460 - $505
1 New
1 $0
Q1 2023

Apr 24, 2023

SELL
$283.23 - $323.1 $4,531 - $5,169
-16 Reduced 14.55%
94 $29,000
Q4 2022

Jan 27, 2023

SELL
$285.76 - $321.48 $4,000 - $4,500
-14 Reduced 11.29%
110 $0
Q3 2022

Oct 27, 2022

BUY
$273.83 - $305.53 $33,954 - $37,885
124 New
124 $36,000
Q1 2020

Apr 22, 2020

SELL
$199.77 - $247.81 $2,397 - $2,973
-12 Closed
0 $0
Q4 2019

Jan 24, 2020

SELL
$166.71 - $223.91 $25,339 - $34,034
-152 Reduced 92.68%
12 $3,000
Q3 2019

Oct 15, 2019

BUY
$166.23 - $187.09 $1,662 - $1,870
10 Added 6.49%
164 $28,000
Q4 2018

Jan 30, 2019

BUY
$151.91 - $192.21 $2,734 - $3,459
18 Added 13.24%
154 $26,000
Q3 2018

Nov 01, 2018

BUY
$167.73 - $192.74 $7,547 - $8,673
45 Added 49.45%
136 $26,000
Q2 2018

Aug 07, 2018

SELL
$145.72 - $169.96 $9,326 - $10,877
-64 Reduced 41.29%
91 $15,000
Q1 2018

May 10, 2018

BUY
$151.6 - $177.13 $2,577 - $3,011
17 Added 12.32%
155 $25,000
Q4 2017

Jan 25, 2018

BUY
$137.28 - $155.55 $17,571 - $19,910
128 Added 1280.0%
138 $21,000
Q3 2017

Nov 01, 2017

BUY
$148.13 - $162.24 $1,481 - $1,622
10
10 $2,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track First Personal Financial Services Portfolio

Follow First Personal Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on First Personal Financial Services with notifications on news.